About Us
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies
A Fully Integrated Global Company
Today, Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.
With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 75 countries, focusing on some of the most complex development areas. Globally, Allucent has worked on more than 825 clinical trials, with oncology representing the majority.
AMERICAS
- Cary, NC
- Houston, TX
- Saint-Laurent, Quebéc
- Research Triangle Park, NC
- Wilmington, NC
- Durham, NC
- Sao Paulo, Brazil
EUROPE
- Amsterdam, Netherlands
- Berkshire, United Kingdom
- Cologne, Germany
- Madrid, Spain
- Milano, Italy
- Munich, Germany
- Paris, France
- Testelt, Belgium
CENTRAL/EASTERN EUROPE
- Bucharest, Romania
- Budapest, Hungary
- Prague, Czech Republic
- Sofia, Bulgaria
- Belgrade, Serbia
- Warsaw, Poland
- Zagreb, Croatia
- Kyiv, Ukraine
- Minsk, Belarus
- Tbilisi, Georgia
ASIA/MIDDLE EAST
- Bangalore, India
- Chennai, India
- Tel Aviv, Israel
